Case Report
Year 2017,
Volume: 9 Issue: 6, 0 - 0, 27.11.2017
Abstract
References
- Kaynaklar 1.www.who.org. 2. Naomi Aronson, Barbara L. Herwaldt, Michael Libman, Ric-hard Pearson, Rogelio Lopez-Velez, Peter Weina, Edgar M.Carvalho, Moshe Ephros, Selma Jeronimo, Alan Magill. Diagnosis and Treatment of Leishmaniasis: ClinicalPractice Guidelines by the Infectious Diseases Society of Ame-rica (IDSA) and the American Society of Tropical Medicineand Hygiene (ASTMH).Clinical Infectious Diseases 2016; Vo-lume 63, Issue 12 pp. 1539-1557. 3.SHYAM Sundar, Vijap P Singh, Nutan K Agrawal, David LGibbs, Henry W Murray. Treatment of Kala Azar with oralFluconazole. The Lancet 1996; August 31; 348:614 4.Torrus D, Boix V, Massa B, Portilla J, Perez MateoM. Flu-conazole plus allopurinol in Treatment of Visceral Leishma-niasis. J Antimicrob Chemother 1996; 37:1042-3 5.Colakoglu M, Fidan Yaylali G, Yalcin Colakoglu N, YilmazM. Successful treatment of visceral leishmaniasis with flu-conazole and allopurinol in a patient with renal failure. ScandJ Infect Dis. 2006;38(3):208-10.
Year 2017,
Volume: 9 Issue: 6, 0 - 0, 27.11.2017
Abstract
Öz
Leismaniasiz: Dünya Sağlık Örgütünün tropikal hastalık programı içinde yer alan,ölümlere yol açabilen önemli bir etkendir. Viseral Leishmaniasis(VL; Kala Azar) hücresel Leismania Donavani etkeninin yol açtığı enfeksiyonu anlatır. Tedavi edilmediğin-de, vücutta kronik tüketime yol açan, hepatosplenomegali, pansitopeni ve hyper gamaglobinemi tablosu ile karakterizedir. VL sıklığının ülkemizde giderek artmaktadır. Sonçalışmalar, Antimon bileşikleri gelişen direnç olgularına ve Amfoterisin-B rejiminin toksik etkilerine dikkat çekmektedir. VL için etkili tedaviye ihtiyacımı vardır. Visseral Leishmaniasiz’de, Flukonazol artı allopurinol tedavisi özellikle az gelişmiş endemik ülkelerde iyi bir rejim olabilir.
References
- Kaynaklar 1.www.who.org. 2. Naomi Aronson, Barbara L. Herwaldt, Michael Libman, Ric-hard Pearson, Rogelio Lopez-Velez, Peter Weina, Edgar M.Carvalho, Moshe Ephros, Selma Jeronimo, Alan Magill. Diagnosis and Treatment of Leishmaniasis: ClinicalPractice Guidelines by the Infectious Diseases Society of Ame-rica (IDSA) and the American Society of Tropical Medicineand Hygiene (ASTMH).Clinical Infectious Diseases 2016; Vo-lume 63, Issue 12 pp. 1539-1557. 3.SHYAM Sundar, Vijap P Singh, Nutan K Agrawal, David LGibbs, Henry W Murray. Treatment of Kala Azar with oralFluconazole. The Lancet 1996; August 31; 348:614 4.Torrus D, Boix V, Massa B, Portilla J, Perez MateoM. Flu-conazole plus allopurinol in Treatment of Visceral Leishma-niasis. J Antimicrob Chemother 1996; 37:1042-3 5.Colakoglu M, Fidan Yaylali G, Yalcin Colakoglu N, YilmazM. Successful treatment of visceral leishmaniasis with flu-conazole and allopurinol in a patient with renal failure. ScandJ Infect Dis. 2006;38(3):208-10.
There are 1 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | Case Report |
| Authors | |
| Publication Date | November 27, 2017 |
| Published in Issue | Year 2017 Volume: 9 Issue: 6 |